How Ketamine Treats Depression
- Published4 Sep 2019
- Source BrainFacts/SfN
In March 2019, the U.S. Food and Drug Administration approved ketamine for the treatment of depression — the first new antidepressant medication in decades. Unlike previous generations of antidepressants, ketamine targets the neurotransmitter glutamate. And, a single dose can work in just a few hours and the effects persist for weeks.
This video won second place in the 2019 Brain Awareness Video Contest.